TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (CDMO), announced today the pricing of $160 million aggregate principal amount of 7.00% Convertible Senior Notes due 2029 (the ...
Avid Bioservices plans to use the net proceeds to repurchase a portion of its 1.250% Exchangeable Senior Notes due 2026 and to repay any remaining 2026 Notes. This move follows an acceleration notice ...
Rezultatele care pot fi inaccesibile pentru dvs. sunt afișate în prezent.
Ascundeți rezultatele inaccesibile